|
related topics |
{product, liability, claim} |
{condition, economic, financial} |
{competitive, industry, competition} |
{property, intellectual, protect} |
{product, candidate, development} |
{financial, litigation, operation} |
{customer, product, revenue} |
{cost, operation, labor} |
{operation, international, foreign} |
{product, market, service} |
{personnel, key, retain} |
{debt, indebtedness, cash} |
|
Risks Relating to Our Company
FDA administrative action could have a material and adverse effect on our business.
On-going antitrust investigations and litigation could have a material and adverse effect on our business.
A catastrophic event at our Norcross, Georgia facility would prevent us from producing many of our reagent products.
Unforeseen product performance problems could prevent us from selling or result in a recall of the affected products.
Poor product performance could increase operating costs and result in the loss of current or future customers.
We are highly dependent on our senior management team and other key employees, and the loss of one or more of these employees could adversely affect our operations.
If customers delay integrating our instruments into their operations, the growth of our business could be negatively impacted.
We may not be successful in capitalizing on the acquisition of our former distribution businesses outside the U.S.
Because we sell our products internationally, we could be adversely affected by fluctuations in foreign currency exchange rates.
Our financial performance is highly dependent on the timely and successful introduction of new products and services.
Our instruments are produced by single source suppliers.
We may be unable to adequately protect our proprietary technology.
Gross margin volatility may negatively impact our profitability.
We have been, and may in the future be, subject to intellectual property rights infringement claims, which are costly to defend, could require us to pay substantial damages and could limit our ability to use certain technologies in the future.
Declining global economic conditions may have a material adverse impact on our results.
Risks Relating to our Industry
Government regulation may delay or prevent new product introduction and affect our ability to continue manufacturing and marketing existing products.
The industry and market segment in which we operate are highly competitive, and we may not be able to compete effectively with larger companies with greater financial resources than we have.
Increased competition in the United States could negatively impact our revenues and profitability.
We may be exposed to product liability claims resulting from the use of products we sell and distribute.
Full 10-K form ▸
|
|
related documents |
736822--8/1/2006--IMMUCOR_INC |
736822--7/27/2007--IMMUCOR_INC |
801898--12/21/2006--JOY_GLOBAL_INC |
1033905--3/16/2006--LUMINEX_CORP |
31791--2/26/2009--PERKINELMER_INC |
880432--9/28/2009--MISONIX_INC |
736822--7/24/2008--IMMUCOR_INC |
880432--9/26/2008--MISONIX_INC |
780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
739944--3/10/2009--MEDTOX_SCIENTIFIC_INC |
65270--7/13/2006--METHODE_ELECTRONICS_INC |
68709--12/2/2009--MTS_SYSTEMS_CORP |
1099800--2/26/2010--Edwards_Lifesciences_Corp |
827156--10/15/2007--ZILA_INC |
827156--10/10/2006--ZILA_INC |
10456--2/19/2009--BAXTER_INTERNATIONAL_INC |
1099800--3/2/2009--Edwards_Lifesciences_Corp |
109831--3/22/2006--INAMED_CORP |
885725--3/1/2006--BOSTON_SCIENTIFIC_CORP |
27096--9/13/2006--DATASCOPE_CORP |
880432--9/28/2007--MISONIX_INC |
715579--3/14/2008--ACNB_CORP |
1103982--2/27/2009--KRAFT_FOODS_INC |
929987--2/22/2006--GUIDANT_CORP |
926763--3/16/2007--ASV_INC_/MN/ |
780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC |
739944--3/15/2007--MEDTOX_SCIENTIFIC_INC |
949491--3/30/2006--VODAVI_TECHNOLOGY_INC |
708850--8/29/2008--DIONEX_CORP_/DE |
918962--3/31/2010--POINDEXTER_J_B_&_CO_INC |
|